奥希替尼联合赛沃替尼二线治疗EGFR-TKI治疗期间T790M突变的转移性NSCLC的临床疗效
汪定军 石蕾 张娟
Clinical efficacy of Osimertinib combined with Savolitinib as second-line therapy for T790M mutation-positive metastatic NSCLC during EGFR-TKI treatment
Wang Dingjun, Shi Lei, Zhang Juan
国际医药卫生导报
.
2024, (16): 2673
-2677
.
DOI: 10.3760/cma.j.issn.1007-1245.2024.16.008
